RELONCHEM LIMITED
Get an alert when RELONCHEM LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£29M
+22.8% highest in 3 filed years
Net assets
£68M
+11% highest in 3 filed years
Employees
22
+37.5% highest in 3 filed years
Profit before tax
£12M
-21.5% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-06-04.
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £46,515,049 | £55,117,832 | £50,632,660 | -8.1% | |
| Operating profit | £15,190,377 | £15,212,004 | £11,948,215 | -21.5% | |
| Profit before tax | £15,190,377 | £15,212,004 | £11,948,215 | -21.5% | |
| Net profit | £11,484,797 | £11,382,816 | £8,972,287 | -21.2% | |
| Cash | £23,532,315 | £23,541,126 | £28,910,782 | +22.8% | |
| Total assets less current liabilities | £49,894,749 | £61,277,565 | £68,020,314 | +11% | |
| Net assets | £49,894,749 | £61,277,565 | £68,020,314 | +11% | |
| Equity | £49,894,749 | £61,277,565 | £68,020,314 | +11% | |
| Average employees | 14 | 16 | 22 | +37.5% | |
| Wages | £1,845,858 | £2,341,904 | £2,643,439 | +12.9% | |
| Directors' remuneration | £1,291,821 | £1,826,573 | £1,144,088 | -37.4% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Operating margin | 32.7% | 27.6% | 23.6% | |
| Net margin | 24.7% | 20.7% | 17.7% | |
| Return on capital employed | 30.4% | 24.8% | 17.6% | |
| Gearing (liabilities / total assets) | 13.2% | 7.7% | 5.8% | |
| Current ratio | 7.25x | 12.24x | 15.54x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PBG Associates Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have assessed the Company's ability to continue as a going concern for a period of at least twelve months from the date of approval of these financial statements. The Company reported a profit of £8,972,287 for the year ended 31 March 2026 (2025: £11,382,816) and maintains a positive net asset position. Based on the Company's financial performance, cash flow forecasts, and continued demand for its pharmaceutical products in both UK and international markets, the Directors consider it appropriate to adopt the going concern basis of accounting.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHISNALL, Daniel | Secretary | 2025-06-25 | — | — |
| CHISNALL, Daniel | Director | 2026-04-01 | May 1996 | British |
| KONASAGAR JAYANNA, Sathish Kumar | Director | 2017-03-31 | Apr 1973 | British |
| MOHANTY, Abhinna Sundar | Director | 2025-06-25 | Oct 1953 | Indian |
| SALDANHA, Mark Bosco | Director | 2008-08-27 | Aug 1972 | Indian |
| SALDANHA, Sandra | Director | 2017-03-31 | Dec 1971 | Indian |
| SHARMA, Jitendra Mahavirprasad | Director | 2008-08-27 | Jun 1969 | Indian |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BARLOW, David | Secretary | 2010-03-31 | 2016-05-31 |
| GILL, Belindar | Secretary | 2005-06-15 | 2005-11-14 |
| JACKS, Gillian | Secretary | 2016-06-01 | 2025-06-26 |
| RAYAT, Satvinder Singh | Secretary | 2005-11-14 | 2007-01-31 |
| RILEY, Deborah Ann | Secretary | 2004-08-19 | 2005-06-15 |
| RUPRAI, Kalvinder Singh | Secretary | 2008-09-09 | 2010-03-31 |
| RUPRAI, Kalvinder Singh | Secretary | 2007-01-26 | 2008-08-27 |
| SOMPURA, Gaurav | Secretary | 2008-08-27 | 2008-09-09 |
| BRIGHTON SECRETARY LTD | Corporate Nominee Secretary | 2003-05-21 | 2003-05-23 |
| BUDDHARAJU, Seetharama Raju | Director | 2020-05-12 | 2025-06-25 |
| HUNTER, Colin | Director | 2019-05-17 | 2024-05-10 |
| JAGDEV, Ravinder Kaur | Director | 2003-05-21 | 2007-02-06 |
| MOLYNEUX, John Stephen | Director | 2024-05-09 | 2026-03-31 |
| ROBERTS, Karl, Dr | Director | 2010-07-19 | 2012-03-19 |
| RUPRAI, Gurdev Singh | Director | 2007-02-06 | 2010-03-31 |
| WILLIAMS, Russell David | Director | 2017-03-31 | 2019-03-27 |
| BRIGHTON DIRECTOR LTD | Corporate Nominee Director | 2003-05-21 | 2003-05-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Marksans Pharma Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 108 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-04 | AA | accounts | Accounts with accounts type full | |
| 2026-04-15 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-03 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-07-01 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-06-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-30 | AA | accounts | Accounts with accounts type full | |
| 2024-09-04 | AA | accounts | Accounts with accounts type full | |
| 2024-05-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-13 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-13 | AP01 | officers | Appoint person director company with name date | |
| 2023-11-06 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-07-15 | AA | accounts | Accounts with accounts type full | |
| 2023-06-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-09 | AA | accounts | Accounts with accounts type full | |
| 2022-05-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-11-02 | AA | accounts | Accounts with accounts type full | |
| 2021-05-28 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.